• Male Breast Carcinoma: Epidemiology, Risk Factors and Current Therapeutic Approaches 

      Zygogianni, A. G.; Kyrgias, G.; Gennatas, C.; Ilknur, A.; Armonis, V.; Tolia, M.; Papaloukas, C.; Pistevou, G.; Kouvaris, J.; Kouloulias, V. (2012)
      Male breast cancer is a very rare disease with an incidence of about 0.5-1% comparing with the one of female breast cancer but relatively little is known about its cause. Treatment strategies for breast cancer in males are ...
    • Prognostic Significance of Serum Inflammatory Response Markers in Newly Diagnosed Non-Small Cell Lung Cancer before Chemoirradiation 

      Tolia, M.; Tsoukalas, N.; Kyrgias, G.; Mosa, E.; Maras, A.; Kokakis, I.; Liakouli, Z.; Kouvaris, J. R.; Liaskonis, K.; Charalampakis, N.; Pistevou-Gombaki, K.; Kelekis, N.; Kouloulias, V. (2015)
      Purpose. To identify whether the serum's baseline C-reactive protein (CRP) and albumin (Alb) levels related to clinicopathological parameters and overall survival (OS) in non-small cell lung cancer (NSCLC). Methods. In ...
    • Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas 

      Tolia, M.; Verganelakis, D.; Tsoukalas, N.; Kyrgias, G.; Papathanasiou, M.; Mosa, E.; Kokakis, I.; Kouvaris, J. R.; Pissakas, G.; Pistevou-Gombaki, K.; Kelekis, N.; Kouloulias, V. (2015)
      Purpose. We studied the prognostic significance of Magnetic Resonance Spectroscopy (MRS) in operated high grade gliomas. Materials and Methods. Twelve patients were treated with radiotherapy and Temozolomide. The MRS data ...
    • Radiotherapy for Hodgkin's lymphoma: too hard to die? 

      Zygogianni, A. G.; Kyrgias, G.; Psyrri, A.; Kantzou, I.; Koumarianou, A.; Tolia, M.; Tsekeris, P.; Tsirigotis, P.; Sarris, G.; Kouvaris, J.; Kouloulias, V. (2012)
      The treatment of Hodgkin's lymphoma (HL) is associated with significant toxicity. The objective of high quality management is to keep the concept of combined modality, while trying to decrease the radiation dose, to diminish ...